4029

GTD Indications Pharmacogenetics GTD Samples Accepted Blood DNA GTD Test Methodology PCR GTD Methodology Notes Targeted Mutation: Mass array (c.1905+1G>A, c.1679T>G, c.2846A>T and c.1236G>A / c.1129– 5923C>G)
Generic Test name (cms title) Dihydropyrimidine dehydrogenase deficiency (DPYD) GTD Test type Targeted Variant GTD Location London Health Sciences Centre GTD Gene/Platform/Region List DPYD
GTD Category Pharmacogenetics GTD Disease/Condition Pharmagogenetics, Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidinuria, DPD deficiency, Familial pyrimidemia, Hereditary thymine-uraciluria